# Lexeo Therapeutics Discusses PKP2 Arrhythmogenic Cardiomyopathy

> Lexeo Therapeutics presents clinical assessment for PKP2 arrhythmogenic cardiomyopathy unmet need.
- Title: Lexeo Therapeutics Discusses PKP2 Arrhythmogenic…
- Summary: Lexeo Therapeutics presents clinical assessment for PKP2 arrhythmogenic cardiomyopathy unmet need. Lexeo Therapeutics discusses clinical assessment and unmet…
- Keywords: lexeo therapeutics, pkp2, arrhythmogenic cardiomyopathy, clinical assessment, unmet need, money, business, Lexeo, Therapeutics, Discusses, Arrhythmogenic, Cardiomyopathy
- Source: Seekingalpha — https://seekingalpha.com/article/4957272-lexeo-therapeutics-inc-lxeo-discusses-clinical-assessment-and-unmet-need-in-pkp2
- Author: SA Transcripts
- Published: 2026-10-24T23:15:03+00:00
- Read time: 1 min
- Topics: lexeo therapeutics, pkp2, arrhythmogenic cardiomyopathy, clinical assessment, unmet need, money, business
## Lexeo Therapeutics
Lexeo Therapeutics published a slide deck discussing clinical assessment and unmet need in PKP2 arrhythmogenic cardiomyopathy.
## Clinical Assessment
The company highlights clinical assessment for PKP2 arrhythmogenic cardiomyopathy unmet need.
## Unmet Need
Lexeo Therapeutics discusses unmet need in PKP2 arrhythmogenic cardiomyopathy.
## Key takeaway

Lexeo Therapeutics discusses clinical assessment and unmet need in PKP2 arrhythmogenic cardiomyopathy.